leisure time -WSS

leisure time

author：fashion 2025-10-01 18:03:25 - browse：8

Humana’s Medicare Advantage enrollees got care in the hospital and physician clinics way more often than the company predicted at the end of 2023, forcing the health insurance giant on Thursday to drastically slash its profit projections for both 2023 and 2024.

Those higher medical costs will wipe away more than $775 million of profit that Humana had expected to bank for 2023. Humana also is “currently assessing the expected impact of emerging utilization trends on its 2024 outlook, which is anticipated to be material if current trends continue,” according to the company’s update to investors.

Humana’s bad news for Wall Street didn’t end there: The company said it appears it only added just 100,000 new Medicare Advantage members from the most recent enrollment period that ended last month — down from estimates that it would enroll anywhere from 325,000 to 435,000 people.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies
Next article： Alkermes shareholders re

hotspot

WSS

Tori Bowie and the unacceptable rates of Black maternal death

Nonprofit, backed by Microsoft, to certify AI tools in health care

JPM 2024: Biotech’s most prolific dealmaker sees a rosy 2024

JPM pitch from hospitals? Revenue streams outside of patient care

Life science postdocs should get big pay hike, NIH panel says

Physician assistants need a new name. Here's what it should be

Wikipedia

leisure time

hotspot

At least 13 dead in Texas as scorching temps continue

Dobbs anniversary: the lost opportunity of abortion as health care

State Dept. review finds Biden bears some blame for Afghanistan failures

STAT Virtual Event: JPM Recap, Live!

Bright Health sells Medicare Advantage business to Molina

JPM 2024: Biotech’s most prolific dealmaker sees a rosy 2024

Heart attack and stroke risk calculators need revising

Alkermes shareholders re

Drug repurposing or repositioning? The language matters

JPM 2024 Review: Hope for the XBI, deals from J&J, Merck, GSK

leisure time

Ascension's ugly legal battle over care for poor patients in Texas

Sports medicine is finally prioritizing gender equality

Supreme Court strikes down use of affirmative action

Mayo Clinic partners with supercomputer AI firm Cerebras at JPM

Male doctors called my cancer incurable. A female doctor showed it wasn't

Activists slam private health insurers over coverage restrictions

focus

hotspot

explore

focus